Stina Singel
Hoofd Techniek/Wetenschap/O&O bij ASCENDIS PHARMA A/S
Vermogen: 368 688 $ op 31-05-2024
Profiel
Stina Singel's career history includes current and former positions as well as education.
Currently, Dr. Singel is the Executive VP & Head-Clinical Development at Ascendis Pharma A.
Previously, Dr. Singel worked as the Senior Medical Director at Genentech, Inc. from 2014 to 2019 and as the SVP, Head-Clinical Development & Drug Safety at Nektar Therapeutics from 2019 to 2020.
Dr. Singel holds a doctorate degree from The Salk Institute for Biological Studies and the University of California San Diego, as well as an undergraduate degree from Harvard University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0.01% | 31-12-2023 | 2 729 ( 0.01% ) | 368 688 $ | 31-05-2024 |
Actieve functies van Stina Singel
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCENDIS PHARMA A/S | Hoofd Techniek/Wetenschap/O&O | 01-05-2020 |
Eerdere bekende functies van Stina Singel
| Bedrijven | Functie | Einde |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01-05-2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2019 |
Opleiding van Stina Singel
| University of California San Diego | Doctorate Degree |
| The Salk Institute for Biological Studies | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ASCENDIS PHARMA A/S | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
